Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleImmunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial.AuthorsViale, G.; de Snoo, F. A.; Slaets, L.; Bogaerts, J.; van ’t Veer, L.; Rutgers, E. J.; Piccart-Gebhart, M. J.; Stork-Sloots, L.; Glas, A.; Russo, L.; Dell’Orto, P.; Tryfonidis, K.; Litière, S.; Cardoso, F.; for the MINDACT investigatorsPublicationBreast Cancer Research & Treatment, 2018, Vol 167, Issue 1, p123ISSN0167-6806Publication typeArticleDOI10.1007/s10549-017-4509-9